
PHILADELPHIA , Sept. 11 (UPI) -- U.S. and Canadian scientists have demonstrated a link between a genetic variant and the effectiveness of the smoking cessation drug bupropion, or Zyban.
People with this variant -- nearly half of Americans of European ancestry -- were less likely than those without it to have resumed smoking six months after treatment with bupropion, reported the study the journal Biological Psychiatry.
Rachel F. Tyndale of the University of Toronto and Caryn Lerman of the University of Pennsylvania in Philadelphia had more than 300 smokers randomly assigned to treatment with either bupropion or a placebo for 10 weeks. Study participants were genetically tested for the presence of a variant form of the CYP2B6 gene,
"This study is part of our ongoing commitment to develop more accurate and personalized approaches to medicine," Dr. Elias A. Zerhouni, director of the National Institutes of Health, in Bethesda, Md., said in a statement.
"This kind of genetic research is helping us to better understand why some people respond to certain smoking cessation treatments and others don't."
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 28 (UPI) --
Rolling Thunder motorcyclists moved into Washington as part of the annual Memorial Day weekend ride held in remembrance of war dead and those missing in action.
|
CALABASAS, Calif., May 28 (UPI) --
Pop singer Justin Bieber is being investigated for battery after allegedly hitting a paparazzo who tried to take pictures of him, California authorities said.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption